RXST
RxSight, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$4.99
+8.71%Next report
Analyst consensus
- Next report date
- Feb 24, 2027
- EPS estimate
- $0.22
- Revenue estimate
- $57.7M
Latest reported
- Last report date
- Nov 3, 2026
- EPS actual
- -$0.39
- EPS estimate
- -$0.31
- Revenue actual
- $24.6M
- Revenue estimate
- $27.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -9.7%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $6.51
- PT range
- $5.50 – $8.00
- Analysts
- 7
1 Buy5 Hold1 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Nov 3, 2026 | -$0.31 | -$0.39 | Miss -27.18% | $24.6M |
| Jul 7, 2026 | -$0.33 | -$0.29 | Beat 11.95% | $33.7M |
| May 6, 2026 | -$0.30 | -$0.38 | Miss -27.14% | $30.9M |
| Feb 25, 2026 | -$0.23 | -$0.22 | Beat 3.37% | $32.6M |
| Nov 5, 2025 | -$0.19 | -$0.04 | Beat 78.95% | $30.3M |
| Aug 7, 2025 | -$0.10 | -$0.08 | Beat 20.00% | $33.6M |
| May 7, 2025 | -$0.04 | -$0.03 | Beat 25.00% | $37.9M |
| Nov 7, 2024 | -$0.25 | -$0.16 | Beat 36.00% | $45.4M |
| Feb 28, 2024 | -$0.36 | -$0.26 | Beat 27.78% | $28.6M |
| Nov 9, 2023 | -$0.42 | -$0.35 | Beat 16.67% | $30.7M |
| Mar 6, 2023 | -$0.72 | -$0.56 | Beat 22.22% | $16.1M |
| May 5, 2022 | -$0.56 | -$0.54 | Beat 3.57% | $8.9M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 24, 2027